Search Results - "COHN, Ronald D"

Refine Results
  1. 1
  2. 2

    A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene by Kemaladewi, Dwi U., Bassi, Prabhpreet S., Erwood, Steven, Al-Basha, Dhekra, Gawlik, Kinga I., Lindsay, Kyle, Hyatt, Elzbieta, Kember, Rebekah, Place, Kara M., Marks, Ryan M., Durbeej, Madeleine, Prescott, Steven A., Ivakine, Evgueni A., Cohn, Ronald D.

    Published in Nature (London) (01-08-2019)
    “…Neuromuscular disorders are often caused by heterogeneous mutations in large, structurally complex genes. Targeting compensatory modifier genes could be…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinically relevant copy number variations detected in cerebral palsy by Oskoui, Maryam, Gazzellone, Matthew J., Thiruvahindrapuram, Bhooma, Zarrei, Mehdi, Andersen, John, Wei, John, Wang, Zhuozhi, Wintle, Richard F., Marshall, Christian R., Cohn, Ronald D., Weksberg, Rosanna, Stavropoulos, Dimitri J., Fehlings, Darcy, Shevell, Michael I., Scherer, Stephen W.

    Published in Nature communications (03-08-2015)
    “…Cerebral palsy (CP) represents a group of non-progressive clinically heterogeneous disorders that are characterized by motor impairment and early age of onset,…”
    Get full text
    Journal Article
  5. 5

    Regulation of Muscle Mass by Follistatin and Activins by Lee, Se-Jin, Lee, Yun-Sil, Zimmers, Teresa A, Soleimani, Arshia, Matzuk, Martin M, Tsuchida, Kunihiro, Cohn, Ronald D, Barton, Elisabeth R

    Published in Molecular endocrinology (Baltimore, Md.) (01-10-2010)
    “…Myostatin is a TGF-β family member that normally acts to limit skeletal muscle mass. Follistatin is a myostatin-binding protein that can inhibit myostatin…”
    Get full text
    Journal Article
  6. 6

    Lethal Disorder of Mitochondrial Fission Caused by Mutations in DNM1L by Yoon, Grace, MD, Malam, Zeenat, PhD, Paton, Tara, PhD, Marshall, Christian R., PhD, Hyatt, Ella, BSc, Ivakine, Zhenya, PhD, Scherer, Stephen W., PhD, Lee, Kyong-Soon, MD, Hawkins, Cynthia, MD, PhD, Cohn, Ronald D., MD

    Published in The Journal of pediatrics (01-04-2016)
    “…We describe two infants with hypotonia, absent respiratory effort, and giant mitochondria in neurons due to compound heterozygosity for 2 nonsense mutations of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Role of TGF-β signaling in inherited and acquired myopathies by Burks, Tyesha N, Cohn, Ronald D

    Published in Skeletal muscle (04-05-2011)
    “…The transforming growth factor-beta (TGF-β) superfamily consists of a variety of cytokines expressed in many different cell types including skeletal muscle…”
    Get full text
    Journal Article
  11. 11

    Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II by Al Teneiji, Amal, Bruun, Theodora U.J., Sidky, Sarah, Cordeiro, Dawn, Cohn, Ronald D, Mendoza-Londono, Roberto, Moharir, Mahendranath, Raiman, Julian, Siriwardena, Komudi, Kyriakopoulou, Lianna, Mercimek-Mahmutoglu, Saadet

    Published in Molecular genetics and metabolism (01-03-2017)
    “…Congenital disorders of glycosylation (CDG) are inborn defects of glycan metabolism. They are multisystem disorders. Analysis of transferrin isoforms is…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing by Garcia, Bianca, Lee, Jooyoung, Edraki, Alireza, Hidalgo-Reyes, Yurima, Erwood, Steven, Mir, Aamir, Trost, Chantel N., Seroussi, Uri, Stanley, Sabrina Y., Cohn, Ronald D., Claycomb, Julie M., Sontheimer, Erik J., Maxwell, Karen L., Davidson, Alan R.

    Published in Cell reports (Cambridge) (12-11-2019)
    “…CRISPR-Cas9 systems provide powerful tools for genome editing. However, optimal employment of this technology will require control of Cas9 activity so that the…”
    Get full text
    Journal Article
  14. 14

    Multi-gene duplication removal in an engineered human cellular MECP2 duplication syndrome model with an IRAK1-MECP2 duplication by Rizvi, Samar Z., Chan, Wing Suen, Maino, Eleonora, Steiman, Sydney, Forguson, Georgiana, Klepfish, Maya, Cohn, Ronald D., Ivakine, Evgueni A.

    Published in Molecular therapy. Nucleic acids (10-12-2024)
    “…Recent progress in genome editing technologies has catalyzed the generation of sophisticated cell models; however, the precise modeling of copy-number…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Editorial: Current Insights Into LAMA2 Disease by Previtali, Stefano C., Cohn, Ronald D., Ruegg, Markus A.

    Published in Frontiers in molecular neuroscience (18-11-2021)
    “…The disease has an estimated prevalence in UK and Italy of 0.6–0.7/100,000, and is characterized by a severe wasting muscular dystrophy, dysmyelinating…”
    Get full text
    Journal Article
  17. 17

    Maintaining skeletal muscle mass: lessons learned from hibernation by Ivakine, Evgueni A., Cohn, Ronald D.

    Published in Experimental physiology (01-04-2014)
    “…New Findings What is the topic of this review? This report describes identification and characterization of serum‐ and glucocorticoid‐regulated kinase 1 (SGK1)…”
    Get full text
    Journal Article
  18. 18

    An Irak1-Mecp2 tandem duplication mouse model for the study of MECP2 duplication syndrome by Maino, Eleonora, Scott, Ori, Rizvi, Samar Z., Chan, Wing Suen, Visuvanathan, Shagana, Zablah, Youssif Ben, Li, Hongbin, Sengar, Ameet S., Salter, Michael W., Jia, Zhengping, Rossant, Janet, Cohn, Ronald D., Gu, Bin, Ivakine, Evgueni A.

    Published in Disease models & mechanisms (01-07-2024)
    “…MECP2 duplication syndrome (MDS) is a neurodevelopmental disorder caused by tandem duplication of the MECP2 locus and its surrounding genes, including IRAK1…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization by Xu, Ran, Andres-Mateos, Eva, Mejias, Rebeca, MacDonald, Elizabeth M., Leinwand, Leslie A., Merriman, Dana K., Fink, Rainer H.A., Cohn, Ronald D.

    Published in Experimental neurology (01-09-2013)
    “…Skeletal muscle atrophy is a very common clinical challenge in many disuse conditions. Maintenance of muscle mass is crucial to combat debilitating functional…”
    Get full text
    Journal Article